Gedeon A, Yab E, Dinut A, Sadowski E, Capton E, Dreneau A
iScience. 2024; 27(10):110967.
PMID: 39429773
PMC: 11489056.
DOI: 10.1016/j.isci.2024.110967.
Hameed P S, Kotakonda H, Sharma S, Nandishaiah R, Katagihallimath N, Rao R
Nat Commun. 2024; 15(1):8202.
PMID: 39294149
PMC: 11410943.
DOI: 10.1038/s41467-024-52557-2.
Kokot M, Minovski N
ACS Omega. 2024; 9(16):18278-18295.
PMID: 38680300
PMC: 11044241.
DOI: 10.1021/acsomega.4c00036.
Collins J, Osheroff N
ACS Infect Dis. 2024; 10(4):1097-1115.
PMID: 38564341
PMC: 11019561.
DOI: 10.1021/acsinfecdis.4c00128.
Kokot M, Novak D, Zdovc I, Anderluh M, Hrast M, Minovski N
Antibiotics (Basel). 2023; 12(5).
PMID: 37237833
PMC: 10215804.
DOI: 10.3390/antibiotics12050930.
Why Matter Matters: Fast-Tracking Drug Discovery.
Ganapathy U, Dick T
Molecules. 2022; 27(20).
PMID: 36296540
PMC: 9608607.
DOI: 10.3390/molecules27206948.
The Structural Features of Novel Bacterial Topoisomerase Inhibitors That Define Their Activity on Topoisomerase IV.
Kokot M, Anderluh M, Hrast M, Minovski N
J Med Chem. 2022; 65(9):6431-6440.
PMID: 35503563
PMC: 9109137.
DOI: 10.1021/acs.jmedchem.2c00039.
A Mycobacterium tuberculosis NBTI DNA Gyrase Inhibitor Is Active against Mycobacterium abscessus.
Ganapathy U, Gonzalez Del Rio R, Cacho-Izquierdo M, Ortega F, Lelievre J, Barros-Aguirre D
Antimicrob Agents Chemother. 2021; 65(12):e0151421.
PMID: 34606340
PMC: 8597734.
DOI: 10.1128/AAC.01514-21.
Structurally Optimized Potent Dual-Targeting NBTI Antibacterials with an Enhanced Bifurcated Halogen-Bonding Propensity.
Kokot M, Weiss M, Zdovc I, Hrast M, Anderluh M, Minovski N
ACS Med Chem Lett. 2021; 12(9):1478-1485.
PMID: 34527181
PMC: 8436411.
DOI: 10.1021/acsmedchemlett.1c00345.
A Fine-Tuned Lipophilicity/Hydrophilicity Ratio Governs Antibacterial Potency and Selectivity of Bifurcated Halogen Bond-Forming NBTIs.
Kolaric A, Kokot M, Hrast M, Weiss M, Zdovc I, Trontelj J
Antibiotics (Basel). 2021; 10(7).
PMID: 34356782
PMC: 8300687.
DOI: 10.3390/antibiotics10070862.
Dioxane-Linked Amide Derivatives as Novel Bacterial Topoisomerase Inhibitors against Gram-Positive .
Lu Y, Papa J, Nolan S, English A, Seffernick J, Shkolnikov N
ACS Med Chem Lett. 2020; 11(12):2446-2454.
PMID: 33335666
PMC: 7734797.
DOI: 10.1021/acsmedchemlett.0c00428.
Two Decades of Successful SAR-Grounded Stories of the Novel Bacterial Topoisomerase Inhibitors (NBTIs).
Kolaric A, Anderluh M, Minovski N
J Med Chem. 2020; 63(11):5664-5674.
PMID: 32027491
PMC: 7307926.
DOI: 10.1021/acs.jmedchem.9b01738.
Crystal structure of 3,6,6-trimethyl-4-oxo-1-(pyridin-2-yl)-4,5,6,7-tetra-hydro-1-indazol-7-aminium chloride and its monohydrate.
Mishnev A, Mengots A, Turks M
Acta Crystallogr E Crystallogr Commun. 2017; 73(Pt 12):1931-1936.
PMID: 29250418
PMC: 5730255.
DOI: 10.1107/S205698901701667X.
In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.
Tan C, Gill C, Wu J, Toussaint N, Yin J, Tsuchiya T
Antimicrob Agents Chemother. 2016; 60(8):4830-9.
PMID: 27246784
PMC: 4958163.
DOI: 10.1128/AAC.00619-16.
Inhibition of Neisseria gonorrhoeae Type II Topoisomerases by the Novel Spiropyrimidinetrione AZD0914.
Kern G, Palmer T, Ehmann D, Shapiro A, Andrews B, Basarab G
J Biol Chem. 2015; 290(34):20984-20994.
PMID: 26149691
PMC: 4543657.
DOI: 10.1074/jbc.M115.663534.
Oxabicyclooctane-linked novel bacterial topoisomerase inhibitors as broad spectrum antibacterial agents.
Singh S, Kaelin D, Wu J, Miesel L, Tan C, Meinke P
ACS Med Chem Lett. 2014; 5(5):609-14.
PMID: 24900889
PMC: 4027601.
DOI: 10.1021/ml500069w.
Architecture and conservation of the bacterial DNA replication machinery, an underexploited drug target.
Robinson A, Causer R, Dixon N
Curr Drug Targets. 2011; 13(3):352-72.
PMID: 22206257
PMC: 3290774.
DOI: 10.2174/138945012799424598.
Exploiting bacterial DNA gyrase as a drug target: current state and perspectives.
Collin F, Karkare S, Maxwell A
Appl Microbiol Biotechnol. 2011; 92(3):479-97.
PMID: 21904817
PMC: 3189412.
DOI: 10.1007/s00253-011-3557-z.
N-Benzyl-3-sulfonamidopyrrolidines are a New Class of Bacterial DNA Gyrase Inhibitors.
Foss M, Hurley K, Sorto N, Lackner L, Thornton K, Shaw J
ACS Med Chem Lett. 2011; 2(4):289-292.
PMID: 21552338
PMC: 3088120.
DOI: 10.1021/ml1002822.
Challenges of antibacterial discovery.
Silver L
Clin Microbiol Rev. 2011; 24(1):71-109.
PMID: 21233508
PMC: 3021209.
DOI: 10.1128/CMR.00030-10.